Breaking News
June 23, 2018 - FDA Alert: Kratom (mitragyna speciosa) powder products by Gaia Ethnobotanical: Recall
June 23, 2018 - CDC chief asks for, and gets, cut to his record $375K pay
June 22, 2018 - Novel cellular pathway may clarify how arterial inflammation develops into atherosclerosis
June 22, 2018 - Rutgers Cancer Institute educates childhood cancer survivors about late effects of treatment
June 22, 2018 - Study tests accuracy of device designed to detect heart dysfunction in childhood cancer survivors
June 22, 2018 - Study links annual haze with increased hospitalizations for respiratory problems
June 22, 2018 - Robotic surgery appears to be as effective as open surgery in treating bladder cancer
June 22, 2018 - Many Drugs Made Available Via FDA Expanded Access Programs
June 22, 2018 - Normal eye dominance is not necessary for restoring visual acuity in amblyopia
June 22, 2018 - Parent-Child Interaction Therapy can reduce depression rates in children
June 22, 2018 - Study provides insights into how components of different cells in the brain are altered
June 22, 2018 - Research does not confirm antidiabetic action of natural fatty acid derivatives
June 22, 2018 - Oxidative stress can be used against tumors to treat cancer
June 22, 2018 - Simple, cost-effective test may help improve early diagnosis of mild cognitive impairment
June 22, 2018 - New guide published to help battle fatal disease caused by kissing bugs
June 22, 2018 - Stigma Adds to Burden of Type 1 Diabetes
June 22, 2018 - In retinoblastoma survivors, oculo-visual issues tied to QoL
June 22, 2018 - Most adults with allergies do not use prescribed epinephrine even in emergency situations
June 22, 2018 - Study provides clues to how cancer cells develop resistance to chemotherapies
June 22, 2018 - New consensus paper serves as basis for uniform medical management of DSD
June 22, 2018 - Researchers work to identify areas of the brain that help us wake up
June 22, 2018 - Alcohol hangovers more significant and costly than people realize, shows research
June 22, 2018 - Targeting cells involved in blood vessel formation could hinder brain tumor growth
June 22, 2018 - Young cancer survivors need more support as they feel dissatisfied with their sexuality
June 22, 2018 - Unusual cell-to-cell communication in glioblastoma promotes aggressiveness and therapy resistance
June 22, 2018 - Turning A Phage – Drug Discovery Today
June 22, 2018 - World-first study links birth interventions and long-term childhood illness
June 22, 2018 - Improving the quality of biomedical research samples
June 22, 2018 - Researchers identify cerebral palsy using AI and DNA sequencing
June 22, 2018 - Administering nitric oxide gas after heart surgery may decrease risk of kidney problems
June 22, 2018 - Measuring levels of ethyl sulphate in hair can help assess alcohol consumption
June 22, 2018 - Researchers develop robot bloodhound that can rapidly detect odors on the ground
June 22, 2018 - AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer
June 22, 2018 - Researchers discover drug compound that inhibits movement of cancer cells
June 22, 2018 - Normalization of ‘plus-size’ body shapes may prevent recognition of health risks of obesity
June 22, 2018 - UC San Diego launches new bacteriophage therapy center
June 22, 2018 - New review outlines current state of sex-sensitive issues linked to heart failure drugs
June 22, 2018 - Pelvic pain a major issue for women nearing mid-life, research reveals
June 22, 2018 - Researchers develop reliable DNA barcodes for biomedical research
June 22, 2018 - New risk-prediction model may help identify diabetic patients at high risk of pancreatic cancer
June 22, 2018 - Study reveals how mTORC1-driven changes in crowding could influence major diseases
June 22, 2018 - Researchers uncover new therapeutic opportunity in the treatment of malignant melanoma
June 22, 2018 - UC Riverside researcher receives grants to advance cancer, ALS research
June 22, 2018 - Radiation therapy alone may be enough to treat older, sicker patients with anal cancers
June 22, 2018 - Technical report describes how to make accurate particle size measurements on carbon black samples
June 22, 2018 - Nocdurna (desmopressin acetate) Approved by FDA as First Sublingual Tablet to Treat Nocturia due to Nocturnal Polyuria
June 22, 2018 - Neuroscientists locate neurons in the brain that respond when a visual target is found
June 22, 2018 - First human Keystone virus infection reported
June 22, 2018 - New study reveals how ‘good’ bacteria help in regulating our metabolism
June 22, 2018 - Osteopathic manual therapy affecting the diaphragm improves chronic low back pain
June 22, 2018 - Researchers create revolutionary model to study pulmonary diseases
June 22, 2018 - Diagnosing Heart Disease Using AI
June 22, 2018 - Increasing biodefense risks posed by synthetic biology
June 22, 2018 - Many Women Report Vasomotor Symptoms in Their 60s
June 22, 2018 - Rare mutation of gene carried by Quebec family gives insight into how the brain is wired
June 22, 2018 - Chemists find new way to make enzymes do a non-natural reaction
June 22, 2018 - Summer is good time to check for signs of skin cancer
June 22, 2018 - Innovative method can help identify patients with spastic cerebral palsy
June 22, 2018 - Exercise alters characteristics of blood to reduce inflammation in obese people
June 22, 2018 - Researchers examine complications across different types of breast reconstructive surgeries
June 22, 2018 - Rhesus macaque model could be useful to test therapies for congenital Zika virus syndrome
June 22, 2018 - AHA: New Insights Into Sickle Cell and Stroke Risk
June 22, 2018 - Doctors prescribe opioids at high rates to those at increased overdose risk
June 22, 2018 - Reduction in US cigarette smoking rates
June 22, 2018 - Preconception binge drinking may have negative effect on future offspring
June 22, 2018 - FDA expands approval of novel diabetes management device to include younger pediatric patients
June 22, 2018 - Researchers confirm weight loss benefits of the 16:8 diet
June 22, 2018 - FDA approves Eversense CGM system for use in adults with diabetes
June 22, 2018 - State opioid monitoring programs are not created equal
June 22, 2018 - Autistic teens who are bullied have higher rates of depression
June 22, 2018 - Penn Medicine team launches universal stroke awareness program
June 22, 2018 - Scientists discover the molecular trigger of necroptosis
June 22, 2018 - Researchers report unusually high levels of herpesvirus in the brains of people with Alzheimer’s disease
June 22, 2018 - Theoretical models predict how juveniles evolve to be more susceptible than adults to infection
June 22, 2018 - USC study reveals how the cell launches emergency response to repair damaged DNA
June 22, 2018 - $1.9 million grant aims to enhance behavioral health services in community-based settings
June 22, 2018 - New 3D imaging technique could improve arthritis treatment
June 22, 2018 - Cytokinetics Announces Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy
June 22, 2018 - Polarized cells give the heart its fully developed form
June 21, 2018 - Stem cells appear to help fight obesity in animal models
A Tribute to Dr. Ray Lipicky: The Man Who Transformed Cardiology

A Tribute to Dr. Ray Lipicky: The Man Who Transformed Cardiology

image_pdfDownload PDFimage_print

Most cardiologists assume that the way we currently think about things in cardiology has always been part of our DNA. We are strongly evidence-based, and we are skeptical of mechanisms that have no supporting data. We recognize the limitation of small trials, and we understand how missing data creates bias. We know that rigorous clinical trials are the only way to inform our use of drugs.

Has cardiology always been this way? Actually, no.

Forty years ago, thinking in cardiology was dominated by wonderful story-telling, but without much evidence. Trials were small, and many were not well designed or executed. They often focused on things that we thought were important, based on our beliefs about a disease. We knew that shortcuts commonly gave the wrong answer, but we embraced them because we did not know better.

One man made all the difference: Dr. Raymond Lipicky.

Ray led the FDA Division of Cardiac and Renal Drug Products from 1981-2002. During those 21 years, his unique intellect and way of thinking transformed the cardiovascular drug evaluation and approval process. Too slowly, his approach to cardiovascular drugs is now being adopted in other therapeutic areas.

What was special about Ray Lipicky? Each of us would probably answer that question a bit differently, as would hundreds of others whom he influenced. But in essence, it all came down to a single summary statement.

He taught us how to challenge the casual assumptions that kept getting in the way of progress.

Ray didn’t provide us with a formula as to how to think. Instead, he was exceptional at challenging our basic thought processes. If we assumed something was true, Ray wanted to know why. If we assumed that there was one way to do something, Ray might suggest three other ways.

His favorite reply: “Why do you think that?”

Many of us who were on the receiving end of that question were often stunned by it. There would be a long moment of silence, often with our jaws wide open. Ray would notice the lack of a response, and he would chuckle.

Ray had a unique chuckle. It was never condescending or judgmental; it was never intended to create discomfort. Its entire purpose was to help the listener move to a new way of thinking. The chuckle gave us permission to laugh at ourselves. When we heard the chuckle, we knew it was time to start paying attention.

Ray always asked the really tough questions. How do you know that ventricular premature beats are bad? How do you know that clots in the coronary arteries are important? How do you know that positive inotropic agents are good for the heart?

He didn’t ask these questions because he thought we would come up with answers. He asked because he wanted us to wonder whether the assumptions we had in our heads were actually true. And he pushed us to come up with a way to test our theories using logic and empirical evidence.

The four of us interacted with Ray in different ways during his tenure at FDA and beyond. Three of us were employed at FDA at various times. But Ray’s influence was felt throughout the academic cardiology community, and it was felt in every sector that was interested in cardiovascular drug development.

In the 1980s and 1990s, if you wanted to learn how to think about therapeutics, all you needed to do was to attend a public meeting of the FDA’s Cardiac and Renal Drugs Advisory Committee. In those days, the meetings discussed the pros and cons of over a dozen new chemical entities each year. At each meeting, the members of the committee typically sat along a linear table in front of an audience that was packed with hundreds of people. Ray Lipicky was at one end of the table, and Dr. Robert Temple (who had preceded Ray as Division Director) was at the other. When they had a discussion or a disagreement, you could hear some amazing intellectual discourse. For all of us, those debates opened our minds and our hearts.

Dr. Ray Lipicky passed away last week.

For everyone who works in the field of cardiology today, the loss is profound. For those of us who knew him, worked with him, learned from him, and were transformed by him, the world is suddenly left without the person who had made such a difference.

Why do we think that? Even though we can no longer hear Ray say those exact words, we will always remember them — and him.

Milton Packer

Robert M. Califf

Norman Stockbridge

Robert R. Fenichel

Packer recently consulted for Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Cardiorentis, Daiichi Sankyo, Gilead, Novo Nordisk, Relypsa, Sanofi, Takeda, and ZS Pharma. He chairs the EMPEROR Executive Committee for trials of empagliflozin for the treatment of heart failure. He was previously the co-PI of the PARADIGM-HF trial and serves on the Steering Committee of the PARAGON-HF trial, but has no financial relationship with Novartis.

1969-12-31T19:00:00-0500

last updated

Tagged with:

About author

Related Articles